Medical Devices Japan

Japan Biological Age Testing Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Japan Biological Age Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $59.2 Mn Placeholder estimate
Estimate 2025 $67.2 Mn 6.6% of the global market
Projected 2034 $210.2 Mn 212.6% Adds $143.0 Mn over 9 forecast years
CAGR 2025–2034 13.5% Faster than 84% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Japan is 6.58% of the global market.
  • In APAC, the largest is China at $93.8 Mn.
  • Fastest growing: India at 16.4% a year.
  • Japan ranks 2nd of 10 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$143.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Biological Age Testing Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $59.2 Mn — —
2025 (base) $67.2 Mn +$8.0 Mn —
2026 (forecast) $76.3 Mn +$9.1 Mn +13.5%
2027 (forecast) $86.6 Mn +$10.3 Mn +28.8%
2028 (forecast) $98.3 Mn +$11.7 Mn +46.2%
2029 (forecast) $111.6 Mn +$13.3 Mn +66%
2030 (forecast) $126.7 Mn +$15.1 Mn +88.4%
2031 (forecast) $143.8 Mn +$17.1 Mn +113.8%
2032 (forecast) $163.2 Mn +$19.4 Mn +142.6%
2033 (forecast) $185.2 Mn +$22.0 Mn +175.4%
2034 (forecast) $210.2 Mn +$25.0 Mn +212.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.02 Bn
  2. North America $520.1 Mn
  3. US $385.1 Mn
  4. APAC $231.2 Mn
  5. Europe $209.2 Mn
  6. China $93.8 Mn
  7. Canada $83.5 Mn
  8. Japan (this report) $67.2 Mn
  9. Latin America $48.1 Mn
  10. Middle East $42.2 Mn
  11. Germany $39.5 Mn
  12. UK $29.0 Mn
  13. Italy $27.6 Mn
  14. Brazil $28.1 Mn
  15. France $26.1 Mn
  16. Ecuador $22.0 Mn
  17. Saudi Arabia $19.1 Mn
  18. India $19.4 Mn
  19. Spain $17.6 Mn
  20. Mexico $17.1 Mn
  21. Africa $17.0 Mn
  22. Australia $12.8 Mn
  23. New Zealand $11.4 Mn
  24. Russia $9.3 Mn
  25. South Africa $7.2 Mn
  26. UAE $5.6 Mn
  27. Egypt $3.3 Mn
  28. Philippines $2.3 Mn
  29. Hong Kong $1.8 Mn
  30. Malaysia $1.5 Mn
  31. Singapore $1.3 Mn
  32. Thailand $1.2 Mn
  33. Kenya $0.8 Mn

Report snapshot

Japan Biological Age Testing Market Analysis at a glance
Market size, 2025$67.2 Mn placeholder estimate
Forecast, 2034$210.2 Mn placeholder estimate
Growth (CAGR), 2025–203413.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, channel and end user (see all)
Key playersTruDiagnostic, Tally Health, InsideTracker, GlycanAge, Elysium Health (see all)
Regulator in JapanPMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan Biological Age Testing Market Analysis Executive Summary

Biological age tests estimate how fast a person is ageing using DNA methylation, blood markers or other data, rather than their age in years.

Key segments of the biological Age Testing market include test (Epigenetic Clocks, Blood Biomarker Panels and Telomere Tests) and channel (Direct-to-Consumer, Clinics and Research).

Bar chart: Japan Biological Age Testing market size, 2024–2034, placeholder estimates. $59.2 Mn in 2024, $67.2 Mn in 2025 and $210.2 Mn in 2034, 13.5% CAGR.
Japan Biological Age Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan Biological Age Testing Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the biological Age Testing market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the biological Age Testing market.

Competitive Landscape for Biological Age Testing Market in Japan

The biological Age Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Biological Age Testing Market in Japan

Biological Age Testing in Japan: rules, payment and health figures

Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare.⁠[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[2] People aged 65 and over: 30.0% of people in 2025, the latest WHO figure for Japan.⁠[3]

[1] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[2] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how biological Age Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Japan.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Biological Age Testing right now, from free public sources.

Latest research 803 papers since 2021 (worldwide)

  1. Premature immune aging in obesity: a testable framework linking immunosenescence, metaflammation, and multiorgan dysfunction. Immunologic research, 2026
  2. The Missing Temporal Coordinate: A Framework for Biopsy Timestamping and Chrono-Biobanking in Precision Oncology and Longevity Medicine. Cureus, 2026
  3. High free sugar dietary pattern, not high fiber-low energy density pattern, predicts increased bipolar disorder risk: Evidence from 124,191 participants. Journal of affective disorders, 2026
  4. Chemotherapy-Induced Biological Age Acceleration and Lifetime Outcomes in Breast Cancer Survivors. JAMA network open, 2026
  5. PTSD is Associated with Advanced Epigenetic Age in 43,155 US Military Veterans. Biological psychiatry, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Biological Age Testing in context

Japan compared

  • People aged 65 and over: 30.0% of people (2025). World: 10.4% of people (2025). Highest of the 16 countries we cover in APAC.[1]
  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 15 countries we cover in APAC.[2]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 15 countries we cover in APAC.[3]

[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Biological Age Testing market in Japan?
Placeholder estimate: about $67.2 Mn in 2025, rising to about $210.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Biological Age Testing market in Japan growing?
Placeholder estimate: about 13.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Biological Age Testing market report cover?
The report splits the market by test (Epigenetic Clocks, Blood Biomarker Panels, Telomere Tests, Multi-Omic Tests), channel (Direct-to-Consumer, Clinics, Research) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Biological Age Testing market?
Key players include TruDiagnostic, Tally Health, InsideTracker, GlycanAge and Elysium Health.
What is driving the Biological Age Testing market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.
Who regulates Biological Age Testing in Japan?
Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare. Source: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
What does WHO report for Japan?
People aged 65 and over: 30.0% of people in 2025, the latest WHO figure. Source: WHO Global Health Observatory, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
How much research is published on Biological Age Testing?
PubMed lists 803 papers on Biological Age Testing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Biological Age Testing in Japan? Our analysts can size it for your plan. Talk to us See the public data People aged 65 and over for every country, free. Open the Public Health Dashboard

From our blog

Bone and Joint Health: Supplements for an Ageing Population1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence… Eye Health Supplements: Screens, Ageing and Vision2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a… Collagen Supplements: Skin, Joints and Real EvidenceCollagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Japan

See all
Same topic, other categories

Related on geriatric and genomics

See the topic